Home >> Current Neuropharmacology, Volume 2, Number 4
Current Neuropharmacology logo Bentham Science Publishers logo

Current Neuropharmacology aims to provide current, timely and comprehensive reviews of all areas of neuropharmacology and related matters of neuroscience. The journal publishes reviews written by experts and leaders in the fields of molecular, cellular, and systems/behavioural aspects of neuropharmacology and neuroscience. The journal serves as a comprehensive, multidisciplinary expert forum for neuropharmacologists and neuroscientists.

Publisher: Bentham Science Publishers

Related content
Volume 2, Number 4, October 2004

< previous issue | all issues | next issue >

Review article

Alpha-2 Adrenoceptor Ligands and Opioid Drugs: Pharmacological Interactions of Therapeutic Interest
pp. 343-352(10)
Authors: L. F. Alguacil; L. Morales

The Clinical Neuroscience of Post Stroke Depression
pp. 353-362(10)
Authors: Ebrahim Haroon; Anand Kumar

Role of Group I Metabotropic Glutamate Receptors mGlu1 and mGlu5 in Nociceptive Signalling
pp. 363-393(31)
Author: A. S.J. Lesage

Buprenorphine: A Unique Drug with Complex Pharmacology
pp. 395-402(8)
Authors: Kabirullah Lutfy; Alan Cowan

Roles for Serotonin in Neurodevelopment: More than just Neural Transmission
pp. 403-417(15)
Authors: G. D. Pino; R. Moessner; K. P. Lesch; J. M. Lauder; A. M. Persico

Histamine as an Anticonvulsant Inhibitory Neurotransmitter
pp. 419-425(7)
Authors: Divya Vohora; S. N. Pal; K. K. Pillai

< previous issue | all issues | next issue >

Marked list

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
^ Back to top
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page